These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23524943)

  • 21. Effects of therapy with amiodarone on clinical, functional, and cardiac sympathetic innervation in patients with idiopathic dilated cardiomyopathy.
    Flotats A; Carrió I
    J Nucl Cardiol; 2004; 11(2):110-3. PubMed ID: 15052240
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrical storm due to amiodarone induced thyrotoxicosis in a young adult with dilated cardiomyopathy: thyroidectomy as the treatment of choice.
    Marketou ME; Simantirakis EN; Manios EG; Vardas PE
    Pacing Clin Electrophysiol; 2001 Dec; 24(12):1827-8. PubMed ID: 11817822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular tachycardia with QRS configuration similar to that in sinus rhythm and a myocardial origin: differential diagnosis with bundle branch reentry.
    Guo H; Hecker S; Lévy S; Olshansky B
    Europace; 2001 Apr; 3(2):115-23. PubMed ID: 11333048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrical storms in an ICD-recipient with 429 delivered appropriate shocks: therapeutic management with antiarrhythmic drug combination.
    Manolis AG; Katsivas AG; Vassilopoulos C; Tsatiris CG
    J Interv Card Electrophysiol; 2002 Feb; 6(1):91-4. PubMed ID: 11839890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Storms of ventricular tachyarrhythmias associated with primary hyperparathyroidism in a patient with dilated cardiomyopathy.
    Kolb C; Lehmann G; Schreieck J; Ndrepepa G; Schmitt C
    Int J Cardiol; 2003 Jan; 87(1):115-6. PubMed ID: 12468064
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful use of intra-aortic counter pulsation therapy for intractable ventricular arrhythmia in patient with severe left ventricular dysfunction and normal coronary arteries.
    Goyal D; Nadar SK; Wrigley B; Koganti S; Banerjee P
    Cardiol J; 2010; 17(4):401-3. PubMed ID: 20690098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proarrhythmic effect of 'Reverse Mode Switch' in a patient with dilated cardiomyopathy and drug-induced long QTc interval.
    De Maria E; Patrizi G; Cappelli S
    Europace; 2015 Mar; 17(3):423. PubMed ID: 25722477
    [No Abstract]   [Full Text] [Related]  

  • 29. Paradoxical ventricular activation sequence and ParaHisian entrainment response: do they challenge the diagnosis?
    Nayyar S; Young GD; Sanders P; Roberts-Thomson KC
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):e1-6. PubMed ID: 23424225
    [No Abstract]   [Full Text] [Related]  

  • 30. Say no to primary prophylaxis with implantable cardioverter-defibrillators in asymptomatic nonischemic dilated cardiomyopathy?
    Jayachandran JV; Zipes DP
    J Am Coll Cardiol; 2003 May; 41(10):1713-5. PubMed ID: 12767652
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term nifekalant use in a patient with dilated cardiomyopathy and recurrent ventricular tachycardia.
    Xiao H; Chen Q; Tao L
    J Int Med Res; 2022 Oct; 50(10):3000605221133704. PubMed ID: 36300319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tachycardia triggering frequent ICD therapy in a patient with dilated cardiomyopathy-what is the mechanism?
    Traykov VB; Pap R; Makai A; Bencsik G; Sághy L
    Pacing Clin Electrophysiol; 2011 Nov; 34(11):1569-72. PubMed ID: 21651589
    [No Abstract]   [Full Text] [Related]  

  • 33. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ranolazine ameliorates postresuscitation electrical instability and myocardial dysfunction and improves survival with good neurologic recovery in a rat model of cardiac arrest.
    Fumagalli F; Russo I; Staszewsky L; Li Y; Letizia T; Masson S; Novelli D; Rocchetti M; Canovi M; Veglianese P; Gobbi M; Latini R; Zaza A; Ristagno G
    Heart Rhythm; 2014 Sep; 11(9):1641-7. PubMed ID: 24858811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological treatment of electrical storm in cathecolaminergic polymorphic ventricular tachycardia.
    Fagundes A; DE Magalhaes LP; Russo M; Xavier E
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):e27-31. PubMed ID: 19889187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study.
    Suzuki T; Shiga T; Wakaumi M; Matsuda N; Ishizuka N; Kasanuki H
    J Cardiol; 2003 Apr; 41(4):169-73. PubMed ID: 12728537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of amiodarone treatment on cardiac symptom, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with beta-blocker therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Cardiol; 2004; 11(2):134-41. PubMed ID: 15052244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is ranolazine an antiarrhythmic drug?
    Eckhardt LL; Teelin TC; January CT
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H1989-91. PubMed ID: 18375723
    [No Abstract]   [Full Text] [Related]  

  • 39. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators.
    Bänsch D; Böcker D; Brunn J; Weber M; Breithardt G; Block M
    J Am Coll Cardiol; 2000 Aug; 36(2):566-73. PubMed ID: 10933373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
    Wang WQ; Robertson C; Dhalla AK; Belardinelli L
    J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.